Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia

被引:87
作者
Mohamed, Uwais
Gollob, Michael H.
Gow, Robert M.
Krahn, Andrew D.
机构
[1] Univ Western Ontario, Div Cardiol, London, England
[2] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada
[3] Univ Ottawa, Inst Heart, Arrhythmia Res Lab, Ottawa, ON, Canada
[4] Univ Ottawa, Childrens Hosp Eastern Ontario, Ottawa, ON, Canada
关键词
catecholamines; implantable cardioverter-defibrillator; sudden death; genetics;
D O I
10.1016/j.hrthm.2006.08.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1486 / 1489
页数:4
相关论文
共 11 条
[1]   Catechotaminergic polymorphic ventricular tachycardia [J].
Francis, J ;
Sankar, V ;
Nair, VK ;
Priori, SG .
HEART RHYTHM, 2005, 2 (05) :550-554
[2]   Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death [J].
Jiang, DW ;
Wang, RW ;
Xiao, BL ;
Kong, HH ;
Hunt, DJ ;
Choi, P ;
Zhang, L ;
Chen, SRW .
CIRCULATION RESEARCH, 2005, 97 (11) :1173-1181
[3]   Diagnosis of unexplained cardiac arrest - Role of adrenaline and procainamide infusion [J].
Krahn, AD ;
Gollob, M ;
Yee, R ;
Gula, LJ ;
Skanes, AC ;
Walker, BD ;
Klein, GJ .
CIRCULATION, 2005, 112 (15) :2228-2234
[4]   A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel [J].
Lahat, H ;
Pras, E ;
Olender, T ;
Avidan, N ;
Ben-Asher, E ;
Man, O ;
Levy-Nissenbaum, E ;
Khoury, A ;
Lorber, A ;
Goldman, B ;
Lancet, D ;
Eldar, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (06) :1378-1384
[5]   CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR-TACHYCARDIA IN CHILDREN - A 7-YEAR FOLLOW-UP OF 21 PATIENTS [J].
LEENHARDT, A ;
LUCET, V ;
DENJOY, I ;
GRAU, F ;
DONGOC, D ;
COUMEL, P .
CIRCULATION, 1995, 91 (05) :1512-1519
[6]   Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak [J].
Lehnart, SE ;
Wehrens, XHT ;
Laitinen, PJ ;
Reiken, SR ;
Deng, SX ;
Cheng, ZZ ;
Landry, DW ;
Kontula, K ;
Swan, H ;
Marks, AR .
CIRCULATION, 2004, 109 (25) :3208-3214
[7]   Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients [J].
Postma, AV ;
Denjoy, I ;
Kamblock, J ;
Alders, M ;
Lupoglazoff, JM ;
Vaksmann, G ;
Dubosq-Bidot, L ;
Sebillon, P ;
Mannens, MMAM ;
Guicheney, P ;
Wilde, AAM .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (11) :863-870
[8]   CELLULAR ELECTROPHYSIOLOGY OF DIGITALIS TOXICITY [J].
ROSEN, MR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (05) :A22-A34
[9]   Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts [J].
Swan, H ;
Piippo, K ;
Viitasalo, M ;
Heikkilä, P ;
Paavonen, T ;
Kainulainen, K ;
Kere, J ;
Keto, P ;
Kontula, K ;
Toivonen, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (07) :2035-2042
[10]   Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: Classification, differential diagnosis, and implications for therapy [J].
Viskin, S ;
Belhassen, B .
PROGRESS IN CARDIOVASCULAR DISEASES, 1998, 41 (01) :17-34